Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia
Zhuang, Jingjing2; Zhang, Haikun2; Zhou, Rong2; Chen, Lili1; Chen, Jing1; Shen, Xu1,2
刊名PROSTAGLANDINS & OTHER LIPID MEDIATORS
2013-10
卷号106页码:45-52
关键词Prostaglandin F-2 alpha Alzheimer's disease A beta clearance Inflammation Microglia
ISSN号1098-8823
DOI10.1016/j.prostaglandins.2013.09.002
文献子类Article
英文摘要Alzheimer's disease (AD) is characterized by extracellular deposit of beta-amyloid (A beta) and accumulation of intracellular neurofibrillary tangles in the brain. Prostaglandin F-2 alpha, (PGF(2 alpha)) is one of the major metabolites of arachidonic acid (AA), and plays essential roles in a series of key physiological processes like luteolysis and parturition. Additionally, PGF(2 alpha) is also involved in the regulation of chronic and acute inflammation processes. Recent clinical studies have revealed the high content of PGE(2 alpha) metabolite, 15-keto-dihydro-PGF(2 alpha) in AD patients, implying the activation of in vivo PGF(2 alpha) biosynthesis. However, the mechanism underlying the involvement of PGF(2 alpha) in the progression of AD still remains unclear. Here we discovered that PGF(2 alpha) selectively antagonized LXR (liver X receptors)/RXR (retinoid X receptor alpha) and RXR/RXR dimers. Cell based assays indicated that PGF(2 alpha) effectively antagonized the activation of LXR agonist (t0901317) on A beta clearance via inhibiting apolipoprotein E (apoE) expression, and cell apoptosis alleviation by accelerating inflammatory response to A beta or Lipopolysaccharide (LPS) in microglia. Therefore, our current findings have addressed the potential association of PGF(2 alpha) with AD progression, and highlighted that inhibition of PGF(2 alpha) biosynthesis might be a useful therapeutic strategy against AD. (C) 2013 Elsevier Inc. All rights reserved.
资助项目National Science & Technology Major Project "Key New Drug Creation. and Manufacturing Program"[2012ZX09103101-018] ; National Science & Technology Major Project "Key New Drug Creation. and Manufacturing Program"[2012ZX09301001-004] ; State Key Program of Basic Research of China[2010CB912501] ; Science Foundation of Shanghai[12431900300]
WOS关键词LIVER-X-RECEPTORS ; CYTOKINE-MEDIATED INFLAMMATION ; ALZHEIMERS-DISEASE ; MOLECULAR-MECHANISMS ; ELDERLY POPULATION ; SIGNALING PATHWAY ; OXIDATIVE STRESS ; A-BETA ; BRAIN ; LXR
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
出版者ELSEVIER SCIENCE INC
WOS记录号WOS:000328720000007
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/277429]  
专题药物安全性评价中心
药理学第三研究室
通讯作者Chen, Jing
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 201203, Peoples R China
2.E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China;
推荐引用方式
GB/T 7714
Zhuang, Jingjing,Zhang, Haikun,Zhou, Rong,et al. Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia[J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS,2013,106:45-52.
APA Zhuang, Jingjing,Zhang, Haikun,Zhou, Rong,Chen, Lili,Chen, Jing,&Shen, Xu.(2013).Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia.PROSTAGLANDINS & OTHER LIPID MEDIATORS,106,45-52.
MLA Zhuang, Jingjing,et al."Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia".PROSTAGLANDINS & OTHER LIPID MEDIATORS 106(2013):45-52.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace